No registrations found.
ID
Source
Brief title
Health condition
IVF, ICSI, X chromosome inactivation, X chromosoom inactivatie
Sponsors and support
Intervention
Outcome measures
Primary outcome
X chromosome inactivation pattern in human surplus embryos
Secondary outcome
Comparison of time pattern of X chromosome inactivation between IVF and ICSI embryos
Background summary
There is concern that in-vitro culture of embryos and/or the ICSI technique might have an adverse effect on embryonic development via epigenetic alterations. In a previous study from our group using blastocysts resulting from surplus embryos obtained after either standard IVF or IVF/ICSI we found a clear sex related growth difference in human blastocysts originating from IVF/ICSI, but not in blastocysts originating from standard IVF. It is as yet unknown which mechanism is responsible for our findings. In in vitro produced female bovine blastocysts it has been shown that both X chromosomes were active while dosage compensation by X-chromosome inactivation did occur in in vivo generated embryos. Therefore, we hypothesize 1) that the process of X-inactivation has a time pattern in human preimplantation embryos comparable with that of the already investigated animal species, and 2) that the ICSI procedure might interfere with the process of X-inactivation in human embryos.
Study objective
The ICSI procedure interferes with the process of X chromosome inactivation in human embryos
Study design
Human surplus embryos at several stages of development (ranging between 8-cell and blastocyst stage) will be collected and analysed for the X chromosome inactivation status.
Intervention
The intervention on the embryos is intracytoplasmic sperm injection (ICSI), which is compared with conventional IVF. ICSI is a regular intervention used in case of male subfertility, where one spermatozoon is injected into an oocyte, while in IVF the spermatozoa and the oocyte are brought together within a culture dish.
Dept. of Obstetrics and Gynaecology
Postbus 5800
A. Montfoort, van
P. Debyelaan 25
Maastricht 6202 AZ
The Netherlands
+ 31 43 3872012
aafke.van.montfoort@mumc.nl
Dept. of Obstetrics and Gynaecology
Postbus 5800
A. Montfoort, van
P. Debyelaan 25
Maastricht 6202 AZ
The Netherlands
+ 31 43 3872012
aafke.van.montfoort@mumc.nl
Inclusion criteria
1. Human surplus embryos, not suitable for transfer or cryopreservation, originating from an IVF or ICSI treatment
2. Informed consent from patients
Exclusion criteria
1. Abnormal fertilized embryos
2. Presence of multinucleated blastomeres
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
NTR-new | NL1253 |
NTR-old | NTR1299 |
Other | CCMO : P05.1655C |
ISRCTN | ISRCTN wordt niet meer aangevraagd. |